‘On-And Off-Ramps’ For Cancer Accelerated Approvals: FDA Suggests Earlier Randomized Trials

Leaders of FDA’s oncology center say sponsors could initiate a single randomized trial prior to receiving accelerated approval or conduct a single-group AA study concurrently with a randomized trial. FDA and sponsor could agree in advance on criteria for approval and withdrawal.

FDA officials make recommendations for navigating on-ramp and off-ramp of accelerated approval pathway • Source: Nielsen Hobbs; the Pink Sheet | Shutterstock images

Leaders of the US Food and Drug Administration’s Oncology Center of Excellence say sponsors can more readily obtain evidence to confirm or refute the clinical benefit of drugs granted accelerated approval by conducting a randomized trial prior to obtaining approval.

In a New England Journal of Medicine perspective piece published on 21 September, they note that oncology drug sponsors...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Review Pathways

More from Pathways & Standards